awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q51557110-281EBF60-D62E-41F3-AE76-3DCF951F8D7B
Q51557110-281EBF60-D62E-41F3-AE76-3DCF951F8D7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51557110-281EBF60-D62E-41F3-AE76-3DCF951F8D7B
Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy.
P2860
Q51557110-281EBF60-D62E-41F3-AE76-3DCF951F8D7B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51557110-281EBF60-D62E-41F3-AE76-3DCF951F8D7B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0d54cd646a98aae124cf4f457c17d63d3a4a53a2
P2860
Sorafenib in advanced clear-cell renal-cell carcinoma